• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种亮氨酸转运蛋白-选择性5-羟色胺再摄取抑制剂结构提示血清素转运体的抗抑郁药特异性

Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures.

作者信息

Zhou Zheng, Zhen Juan, Karpowich Nathan K, Law Christopher J, Reith Maarten E A, Wang Da-Neng

机构信息

Kimmel Center for Biology and Medicine at the Skirball Institute of Biomolecular Medicine, Department of Cell Biology, New York University School of Medicine, New York, New York, USA.

出版信息

Nat Struct Mol Biol. 2009 Jun;16(6):652-7. doi: 10.1038/nsmb.1602. Epub 2009 May 10.

DOI:10.1038/nsmb.1602
PMID:19430461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2758934/
Abstract

Sertraline and fluoxetine are selective serotonin re-uptake inhibitors (SSRIs) that are widely prescribed to treat depression. They exert their effects by inhibiting the presynaptic plasma membrane serotonin transporter (SERT). All SSRIs possess halogen atoms at specific positions, which are key determinants for the drugs' specificity for SERT. For the SERT protein, however, the structural basis of its specificity for SSRIs is poorly understood. Here we report the crystal structures of LeuT, a bacterial SERT homolog, in complex with sertraline, R-fluoxetine or S-fluoxetine. The SSRI halogens all bind to exactly the same pocket within LeuT. Mutation at this halogen-binding pocket (HBP) in SERT markedly reduces the transporter's affinity for SSRIs but not for tricyclic antidepressants. Conversely, when the only nonconserved HBP residue in both norepinephrine and dopamine transporters is mutated into that found in SERT, their affinities for all the three SSRIs increase uniformly. Thus, the specificity of SERT for SSRIs is dependent largely on interaction of the drug halogens with the protein's HBP.

摘要

舍曲林和氟西汀是选择性5-羟色胺再摄取抑制剂(SSRI),被广泛用于治疗抑郁症。它们通过抑制突触前质膜5-羟色胺转运体(SERT)发挥作用。所有SSRI在特定位置都含有卤素原子,这些卤素原子是药物对SERT特异性的关键决定因素。然而,对于SERT蛋白,其对SSRI特异性的结构基础仍知之甚少。在此我们报道了细菌SERT同源物亮氨酸转运蛋白(LeuT)与舍曲林、R-氟西汀或S-氟西汀结合的晶体结构。SSRI的卤素都与LeuT内完全相同的口袋结合。SERT中该卤素结合口袋(HBP)处的突变显著降低了转运体对SSRI的亲和力,但对三环类抗抑郁药的亲和力未产生影响。相反,当去甲肾上腺素和多巴胺转运体中唯一的非保守HBP残基突变为SERT中的残基时,它们对所有三种SSRI的亲和力均一致增加。因此,SERT对SSRI的特异性很大程度上取决于药物卤素与蛋白HBP的相互作用。

相似文献

1
Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures.三种亮氨酸转运蛋白-选择性5-羟色胺再摄取抑制剂结构提示血清素转运体的抗抑郁药特异性
Nat Struct Mol Biol. 2009 Jun;16(6):652-7. doi: 10.1038/nsmb.1602. Epub 2009 May 10.
2
Structural basis for action by diverse antidepressants on biogenic amine transporters.各种抗抑郁药作用于生物胺转运体的结构基础。
Nature. 2013 Nov 7;503(7474):141-5. doi: 10.1038/nature12648. Epub 2013 Oct 13.
3
Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands - Fluoxetine and fluvoxamine.通过引入卤素原子来调节已知药物的活性——以 SERT 配体氟西汀和氟伏沙明为例。
Eur J Med Chem. 2021 Aug 5;220:113533. doi: 10.1016/j.ejmech.2021.113533. Epub 2021 May 14.
4
Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.脑内5-羟色胺转运体结合、血浆浓度与选择性5-羟色胺再摄取抑制剂行为效应之间的关系。
Br J Pharmacol. 2005 Mar;144(5):695-702. doi: 10.1038/sj.bjp.0706108.
5
Molecular basis for selective serotonin reuptake inhibition by the antidepressant agent fluoxetine (Prozac).抗抑郁药氟西汀(百忧解)选择性抑制 5-羟色胺再摄取的分子基础。
Mol Pharmacol. 2014 May;85(5):703-14. doi: 10.1124/mol.113.091249. Epub 2014 Feb 10.
6
LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake.亮氨酸转运体-去甲丙咪嗪结构揭示了抗抑郁药如何阻断神经递质再摄取。
Science. 2007 Sep 7;317(5843):1390-3. doi: 10.1126/science.1147614. Epub 2007 Aug 9.
7
Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane.细胞内的选择性 5-羟色胺再摄取抑制剂:细胞质、内质网和膜中的时间分辨率。
J Neurosci. 2023 Mar 29;43(13):2222-2241. doi: 10.1523/JNEUROSCI.1519-22.2022. Epub 2023 Mar 3.
8
Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.低压缺氧暴露会使选择性 5-羟色胺再摄取抑制剂氟西汀、帕罗西汀、艾司西酞普兰和舍曲林对大鼠的抗抑郁作用产生差异。
Pharmacol Biochem Behav. 2018 Jul;170:25-35. doi: 10.1016/j.pbb.2018.05.002. Epub 2018 May 5.
9
Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.与急性阻断5-羟色胺转运体相比,抗抑郁药引起的5-羟色胺转运体下调对体内5-羟色胺清除率的影响更大。
J Neurosci. 2002 Aug 1;22(15):6766-72. doi: 10.1523/JNEUROSCI.22-15-06766.2002.
10
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.去甲肾上腺素和5-羟色胺转运体表达变化与抗抑郁药物长期行为效应的关联
Neuropsychopharmacology. 2009 May;34(6):1467-81. doi: 10.1038/npp.2008.183. Epub 2008 Oct 15.

引用本文的文献

1
Uncovering the Elusive Structures and Mechanisms of Prevalent Antidepressants.揭示常见抗抑郁药难以捉摸的结构和作用机制。
Adv Ther (Weinh). 2024 Sep;7(9). doi: 10.1002/adtp.202400117. Epub 2024 Jul 31.
2
Fluvoxamine: First comprehensive insights into its molecular characteristics and inclusion complexation with β-cyclodextrin.氟伏沙明:对其分子特性以及与β-环糊精包合作用的首次全面见解。
J Pharm Anal. 2025 Jan;15(1):101040. doi: 10.1016/j.jpha.2024.101040. Epub 2024 Jul 14.
3
Psilocybin in pharmacotherapy of obsessive-compulsive disorder.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Binding of an octylglucoside detergent molecule in the second substrate (S2) site of LeuT establishes an inhibitor-bound conformation.辛基葡糖苷去污剂分子与亮氨酸转运蛋白(LeuT)的第二个底物(S2)位点结合,形成一种抑制剂结合构象。
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5563-8. doi: 10.1073/pnas.0811322106. Epub 2009 Mar 23.
3
Structure and localisation of drug binding sites on neurotransmitter transporters.
迷幻蘑菇在强迫症药物治疗中的应用。
Pharmacol Rep. 2024 Oct;76(5):911-925. doi: 10.1007/s43440-024-00633-1. Epub 2024 Aug 1.
4
Cryo-EM structure of the dopamine transporter with a novel atypical non-competitive inhibitor bound to the orthosteric site.与结合于正构位点的新型非典型非竞争性抑制剂结合的多巴胺转运体的冷冻电镜结构。
J Neurochem. 2024 Sep;168(9):2043-2055. doi: 10.1111/jnc.16179. Epub 2024 Jul 15.
5
Truly-Biocompatible Gold Catalysis Enables Vivo-Orthogonal Intra-CNS Release of Anxiolytics.真正具有生物相容性的金催化实现了抗焦虑药物在中枢神经系统内的体内正交释放。
Angew Chem Weinheim Bergstr Ger. 2022 Jan 3;134(1):e202111461. doi: 10.1002/ange.202111461. Epub 2021 Nov 18.
6
Taurine and Creatine Transporters as Potential Drug Targets in Cancer Therapy.牛磺酸和肌酸转运蛋白作为癌症治疗的潜在药物靶点。
Int J Mol Sci. 2023 Feb 14;24(4):3788. doi: 10.3390/ijms24043788.
7
The serotonin theory of depression: a systematic umbrella review of the evidence.抑郁的 5-羟色胺理论:证据的系统伞状评价。
Mol Psychiatry. 2023 Aug;28(8):3243-3256. doi: 10.1038/s41380-022-01661-0. Epub 2022 Jul 20.
8
Novel Molecular Targets of Antidepressants.抗抑郁药的新型分子靶点。
Molecules. 2022 Jan 14;27(2):533. doi: 10.3390/molecules27020533.
9
Inclusion Scenarios and Conformational Flexibility of the SSRI Paroxetine as Perceived from Polymorphism of β-Cyclodextrin-Paroxetine Complex.从β-环糊精-帕罗西汀复合物的多晶型现象看选择性5-羟色胺再摄取抑制剂(SSRI)帕罗西汀的包合情况及构象灵活性
Pharmaceuticals (Basel). 2022 Jan 14;15(1):98. doi: 10.3390/ph15010098.
10
Glycine Transporter 2: Mechanism and Allosteric Modulation.甘氨酸转运体2:机制与变构调节
Front Mol Biosci. 2021 Nov 5;8:734427. doi: 10.3389/fmolb.2021.734427. eCollection 2021.
神经递质转运体上药物结合位点的结构与定位
J Mol Model. 2009 Oct;15(10):1155-64. doi: 10.1007/s00894-009-0478-1. Epub 2009 Feb 24.
4
A competitive inhibitor traps LeuT in an open-to-out conformation.竞争性抑制剂将亮氨酸转运体(LeuT)捕获在一种胞外向胞内开放的构象中。
Science. 2008 Dec 12;322(5908):1655-61. doi: 10.1126/science.1166777.
5
The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site.神经递质-钠同向转运体的机制——第二个结合位点中的底物触发Na⁺和底物的内向释放。
Mol Cell. 2008 Jun 20;30(6):667-77. doi: 10.1016/j.molcel.2008.05.008.
6
From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.从选择性5-羟色胺转运体抑制剂西酞普兰到选择性去甲肾上腺素转运体抑制剂他洛普仑:合成及构效关系研究
J Med Chem. 2008 May 22;51(10):3045-8. doi: 10.1021/jm701602g. Epub 2008 Apr 23.
7
Salt-bridge dynamics control substrate-induced conformational change in the membrane transporter GlpT.盐桥动力学控制膜转运蛋白GlpT中底物诱导的构象变化。
J Mol Biol. 2008 May 9;378(4):828-39. doi: 10.1016/j.jmb.2008.03.029. Epub 2008 Mar 19.
8
Sodium-coupled neurotransmitter transporters.钠偶联神经递质转运体
Chem Rev. 2008 May;108(5):1654-68. doi: 10.1021/cr078246a. Epub 2008 Apr 5.
9
Comparative molecular field analysis using selectivity fields reveals residues in the third transmembrane helix of the serotonin transporter associated with substrate and antagonist recognition.使用选择性场的比较分子场分析揭示了血清素转运体第三个跨膜螺旋中与底物和拮抗剂识别相关的残基。
J Pharmacol Exp Ther. 2008 Jun;325(3):791-800. doi: 10.1124/jpet.108.136200. Epub 2008 Mar 19.
10
Fluorine in pharmaceuticals: looking beyond intuition.药物中的氟:超越直觉的探索。
Science. 2007 Sep 28;317(5846):1881-6. doi: 10.1126/science.1131943.